ALOX5 and asthma: In the only study in children to date, Mougey and colleagues19 measured urinary leukotriene E4 and identified ALOX5 polymorphism status in 270 6–17-year-old children with poorly controlled asthma enrolled into a 6 month (negative) trial of acid-reflux treatment.